894 related articles for article (PubMed ID: 34032727)
1. Cardiovascular magnetic resonance image analysis and mechanism study for the changes after treatments for primary microvascular angina pectoris.
Huang Q; Wang WT; Wang SS; Pei A; Sui XQ
Medicine (Baltimore); 2021 May; 100(21):e26038. PubMed ID: 34032727
[TBL] [Abstract][Full Text] [Related]
2. Correlation and mechanism between cardiac magnetic resonance imaging and oral streptococcus count in patients with primary microvascular angina pectoris.
Huang Q; Wang SS; Luo RH
Medicine (Baltimore); 2022 Mar; 101(12):e29060. PubMed ID: 35357350
[TBL] [Abstract][Full Text] [Related]
3. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
Guermonprez JL; Blin P; Peterlongo F
Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab-Related Microvascular Angina and Its Management with Nicorandil.
Katoh M; Takeda N; Arimoto T; Abe H; Oda K; Osuga Y; Fujii T; Komuro I
Int Heart J; 2017 Oct; 58(5):803-805. PubMed ID: 28966326
[TBL] [Abstract][Full Text] [Related]
5. A randomized, single-center double-blinded trial on the effects of diltiazem sustained-release capsules in patients with coronary slow flow phenomenon at 6-month follow-up.
Li L; Gu Y; Liu T; Bai Y; Hou L; Cheng Z; Hu L; Gao B
PLoS One; 2012; 7(6):e38851. PubMed ID: 22761709
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness and safety of nicorandil in the treatment of patients with microvascular angina: A protocol for systematic review and meta-analysis.
Zhang Y; Wang X; Liu R; Li Q; Tian W; Lei H; Shi C
Medicine (Baltimore); 2021 Jan; 100(2):e23888. PubMed ID: 33466132
[TBL] [Abstract][Full Text] [Related]
7. Nicorandil Versus Nitroglycerin for Symptomatic Relief of Angina in Patients With Slow Coronary Flow Phenomenon: A Randomized Clinical Trial.
Sani HD; Eshraghi A; Nezafati MH; Vojdanparast M; Shahri B; Nezafati P
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):401-6. PubMed ID: 25701829
[TBL] [Abstract][Full Text] [Related]
8. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina.
Chen JW; Lee WL; Hsu NW; Lin SJ; Ting CT; Wang SP; Chang MS
Am J Cardiol; 1997 Jul; 80(1):32-8. PubMed ID: 9205016
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of massive oral nicorandil in a patient with variant angina refractory to conventional treatment.
Kurisu S; Inoue I; Kawagoe T; Ishihara M; Shimatani Y; Nishioka K; Nakamura S; Umemura T; Yoshida M
Intern Med; 2003 Feb; 42(2):163-7. PubMed ID: 12636235
[TBL] [Abstract][Full Text] [Related]
11. Effect of Nicorandil, Diltiazem, or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts-A Pilot Randomized Controlled Trial (ASRAB-Pilot): Rationale and Study Protocol.
Zhu Y; Qin K; Liu Y; Yao H; Zhang W; Zhao Q
Adv Ther; 2023 Aug; 40(8):3588-3597. PubMed ID: 37329403
[TBL] [Abstract][Full Text] [Related]
12. The effect of nicorandil in patients with cardiac syndrome X: A meta-analysis of randomized controlled trials.
Jia Q; Shi S; Yuan G; Shi J; Shi S; Wei Y; Hu Y
Medicine (Baltimore); 2020 Sep; 99(37):e22167. PubMed ID: 32925783
[TBL] [Abstract][Full Text] [Related]
13. Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging.
Yamada K; Isobe S; Ishii H; Yokouchi K; Iwata H; Sawada K; Murohara T
Heart Vessels; 2016 Sep; 31(9):1430-7. PubMed ID: 26531829
[TBL] [Abstract][Full Text] [Related]
14. Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial.
Zhang W; Dai J; Zheng X; Xu K; Yang X; Shen L; Wang X; Hao Z; Qiu X; Jiang L; Shi H; Shen L; He B
Medicine (Baltimore); 2021 Apr; 100(15):e25551. PubMed ID: 33847683
[TBL] [Abstract][Full Text] [Related]
15. Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
Foley M; Rajkumar CA; Shun-Shin M; Ganesananthan S; Seligman H; Howard J; Nowbar AN; Keeble TR; Davies JR; Tang KH; Gerber R; O'Kane P; Sharp ASP; Petraco R; Malik IS; Nijjer S; Sen S; Francis DP; Al-Lamee R
J Am Heart Assoc; 2021 Feb; 10(3):e017381. PubMed ID: 33496201
[TBL] [Abstract][Full Text] [Related]
16. Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery.
Zhao N; Xu J; Singh B; Yu X; Wu T; Huang Y
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010726. PubMed ID: 27488764
[TBL] [Abstract][Full Text] [Related]
17. REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER).
Huang D; Qian J; Ge L; Jin X; Jin H; Ma J; Liu Z; Zhang F; Dong L; Wang X; Yao K; Ge J
Am Heart J; 2012 Sep; 164(3):394-401. PubMed ID: 22980307
[TBL] [Abstract][Full Text] [Related]
18. Coronary Microvascular Dysfunction as a Mechanism of Angina in Severe AS: Prospective Adenosine-Stress CMR Study.
Ahn JH; Kim SM; Park SJ; Jeong DS; Woo MA; Jung SH; Lee SC; Park SW; Choe YH; Park PW; Oh JK
J Am Coll Cardiol; 2016 Mar; 67(12):1412-1422. PubMed ID: 27012401
[TBL] [Abstract][Full Text] [Related]
19. Antianginal efficacy and safety of controlled-delivery diltiazem QD versus an equivalent dose of immediate-release diltiazem TID.
Klinke WP; Baird M; Juneau M; Waters D; Warnica W; Lakhani Z; Annable L; Boulet AP; Larivière L
Cardiovasc Drugs Ther; 1995 Apr; 9(2):319-30. PubMed ID: 7662599
[TBL] [Abstract][Full Text] [Related]
20. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
